Circulating IGFBP‐2: a novel biomarker for incident dementia

Objective To determine the association between plasma insulin‐like growth factor binding protein 2 (IGFBP‐2) and cognitive outcomes. Methods We measured plasma IGFBP‐2 levels in 1596 (53% women, mean age 68.7 [SD 5.7] years) dementia‐free Framingham Offspring cohort participants between 1998 and 200...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Annals of clinical and translational neurology Ročník 6; číslo 9; s. 1659 - 1670
Hlavní autoři:	McGrath, Emer R., Himali, Jayandra J., Levy, Daniel, Conner, Sarah C., DeCarli, Charles S., Pase, Matthew P., Courchesne, Paul, Satizabal, Claudia L., Vasan, Ramachandran S., Beiser, Alexa S., Seshadri, Sudha
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States John Wiley & Sons, Inc 01.09.2019 John Wiley and Sons Inc Wiley
Témata:	Aged Alzheimer Disease - blood Alzheimer Disease - diagnosis Alzheimer Disease - epidemiology Alzheimer's disease Biomarkers Biomarkers - blood Cognitive ability Dementia Dementia - blood Dementia - diagnosis Dementia - epidemiology Female Growth factors Humans Incidence Insulin resistance Insulin-Like Growth Factor Binding Protein 3 - blood Male Metabolism Middle Aged NMR Nuclear magnetic resonance Probability Prospective Studies Proteins Risk
ISSN:	2328-9503, 2328-9503
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!